A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays.

RNA interference (RNAi) high-throughput screening (HTS) enables massive parallel gene silencing and is increasingly being used to reveal novel connections between genes and disease-relevant phenotypes. The application of genome-scale RNAi relies on the development of high-quality RNAi HTS assays. To obtain high-quality HTS assays, there is a strong need for an easily interpretable and theoretically based quality control (QC) metric. Signal-to-noise ratio (S/N), signal-to-background ratio (S/B), and Z-factor have been adopted as QC metrics in HTS assays. In this paper, I proposed a pair of new parameters, strictly standardized mean difference (SSMD) and coefficient of variability in difference (CVD), as QC metrics in RNAi HTS assays. Compared to S/B and S/N, SSMD and CVD capture the variabilities in both compared populations. Compared to Z-factor, SSMD and CVD have a clear probability interpretation and a solid statistical basis. Accordingly, the cutoff criteria of using SSMD or CVD as a QC metric in HTS assays are fully theoretically based. In addition, I discuss the relationship between the SSMD-based criterion and the popular Z-factor-based criterion and elucidate why p-value from t-test of testing mean difference fails to serve as a QC metric.

[1]  N. Perrimon,et al.  A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway , 2005, Nature Genetics.

[2]  V. Makarenkov,et al.  Statistical Analysis of Systematic Errors in High-Throughput Screening , 2005, Journal of biomolecular screening.

[3]  Mengxiang Tang,et al.  Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. , 2004, Nucleic acids research.

[4]  Bert Gunter,et al.  Statistical and Graphical Methods for Quality Control Determination of High-Throughput Screening Data , 2003, Journal of biomolecular screening.

[5]  J. Whelan First clinical data on RNAi. , 2005, Drug discovery today.

[6]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[7]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[8]  M. Schervish Theory of Statistics , 1995 .

[9]  James Inglese,et al.  A cell-based β-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication , 2004 .

[10]  Marc Ferrer,et al.  Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. , 2006, Pharmacogenomics.

[11]  Andreas Schwienhorst,et al.  Thrombin inhibitors identified by computer-assisted multiparameter design. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Dennis,et al.  Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth. , 2006, Cancer research.

[13]  C. Parker,et al.  A High Throughput Screen for Inhibitors of Fungal Cell Wall Synthesis , 2002, Journal of biomolecular screening.

[14]  Gregory J. Hannon,et al.  RNAi: A Guide to Gene Silencing , 2003 .

[15]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[16]  Bert Gunter,et al.  Improved Statistical Methods for Hit Selection in High-Throughput Screening , 2003, Journal of biomolecular screening.

[17]  Nagesh Mahanthappa,et al.  Translating RNA interference into therapies for human disease. , 2005, Pharmacogenomics.

[18]  Jeffrey P. MacKeigan,et al.  Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance , 2005, Nature Cell Biology.

[19]  R. Kirk Practical Significance: A Concept Whose Time Has Come , 1996 .

[20]  Bianca Habermann,et al.  Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis , 2005, Nature.